save $20
Buy Our Exclusive 5-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS) and Save $20
Reviews
PHASE 3 CLINICAL TRIAL CONFIRMS SANOTIZE’S TREATMENT IS 99% EFFECTIVE AGAINST COVID-19!
On Feb 9, 2022 SaNOtize announced the completion of Phase 3 trial in India for its nitric oxide nasal spray. The trial reached primary endpoint:
Reduction in SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hoursThe double-blind, parallel arm, multicenter study, conducted in 306 patients in non-hospitalized adult patients. NONS was safe and well tolerated by patients. No patients experienced moderate, severe, serious Adverse Events (AE) or death in the study.
Sold Out
Quick view

Sold Out
Quick view

Sold Out
Quick view

Sold Out
Quick view

Sold Out
Quick view

Sold Out
Quick view
